Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$34.6M Sell
1,233,510
-2,051
-0.2% -$54.6K 0.99% 23
2025
Q4
$30.8M Sell
1,235,561
-18,326
-1% -$462K 0.92% 24
2025
Q3
$31.9M Sell
1,253,887
-54,872
-4% -$1.35M 0.95% 22
2025
Q2
$31.7M Sell
1,308,759
-5,952
-0.5% -$139K 1.02% 25
2025
Q1
$33.3M Sell
1,314,711
-34,179
-3% -$894K 1.17% 22
2024
Q4
$35.8M Sell
1,348,890
-999
-0.1% -$27.1K 1.29% 22
2024
Q3
$39.1M Buy
1,349,889
+4,912
+0.4% +$143K 1.32% 20
2024
Q2
$37.6M Buy
1,344,977
+79,958
+6% +$2.2M 1.29% 19
2024
Q1
$35.1M Buy
1,265,019
+161,535
+15% +$4.48M 1.17% 22
2023
Q4
$31.8M Buy
1,103,484
+25,366
+2% +$767K 1.16% 20
2023
Q3
$35.8M Sell
1,078,118
-9,512
-0.9% -$336K 1.38% 14
2023
Q2
$39.9M Buy
1,087,630
+4,201
+0.4% +$164K 1.59% 13
2023
Q1
$44.2M Buy
1,083,429
+10,843
+1% +$468K 1.78% 11
2022
Q4
$55M Buy
1,072,586
+308
+0% +$14.8K 2.24% 6
2022
Q3
$46.9M Buy
1,072,278
+1,200
+0.1% +$58.3K 2.03% 6
2022
Q2
$56.2M Sell
1,071,078
-157
-0% -$8K 2.47% 5
2022
Q1
$55.5M Sell
1,071,235
-6,641
-0.6% -$345K 2.28% 6
2021
Q4
$63.6M Sell
1,077,876
-967
-0.1% -$47.9K 2.72% 5
2021
Q3
$46.4M Sell
1,078,843
-4,516
-0.4% -$200K 2.14% 8
2021
Q2
$42.4M Sell
1,083,359
-16,234
-1% -$631K 1.95% 10
2021
Q1
$39.8M Sell
1,099,593
-844
-0.1% -$30K 1.89% 10
2020
Q4
$40.5M Sell
1,100,437
-61,481
-5% -$2.26M 2.17% 8
2020
Q3
$40.5M Buy
1,161,918
+4,495
+0.4% +$158K 2.5% 7
2020
Q2
$35.9M Buy
1,157,423
+8,166
+0.7% +$277K 2.13% 7
2020
Q1
$35.6M Sell
1,149,257
-970
-0.1% -$33.1K 2.68% 6
2019
Q4
$42.8M Hold
1,150,227
2.19% 7
2019
Q3
$39.2M Sell
1,150,227
-2,049
-0.2% -$74.5K 2.06% 7
2019
Q2
$47.4M Sell
1,152,276
-5,237
-0.5% -$208K 2.59% 5
2019
Q1
$46.6M Sell
1,157,513
-104
-0% -$4.17K 2.52% 5
2018
Q4
$47.9M Buy
1,157,617
+482
+0% +$20K 2.67% 3
2018
Q3
$48.4M Sell
1,157,135
-3,742
-0.3% -$144K 2.22% 4
2018
Q2
$40M Sell
1,160,877
-1,317
-0.1% -$45K 1.93% 5
2018
Q1
$39.1M Buy
1,162,194
+61,583
+6% +$2.12M 2.08% 6
2017
Q4
$37.8M Sell
1,100,611
-2,635
-0.2% -$89.8K 1.98% 8
2017
Q3
$37.4M Buy
1,103,246
+317
+0% +$10.2K 2.31% 6
2017
Q2
$35.1M Sell
1,102,929
-5,168
-0.5% -$163K 2.4% 6
2017
Q1
$36M Buy
1,108,097
+7,378
+0.7% +$233K 2.2% 5
2016
Q4
$33.9M Sell
1,100,719
-9,059
-0.8% -$277K 2.06% 6
2016
Q3
$35.7M Buy
1,109,778
+106
+0% +$3.54K 2.62% 4
2016
Q2
$37.1M Sell
1,109,672
-323
-0% -$10.3K 2.52% 4
2016
Q1
$31.2M Sell
1,109,995
-1,074
-0.1% -$30.7K 1.96% 6
2015
Q4
$34M Buy
1,111,069
+211
+0% +$6.64K 2.04% 7
2015
Q3
$33.1M Sell
1,110,858
-2,984
-0.3% -$95.7K 1.88% 6
2015
Q2
$35.4M Sell
1,113,842
-2,530
-0.2% -$82.5K 2.03% 7
2015
Q1
$36.8M Sell
1,116,372
-2,424
-0.2% -$77.1K 2.17% 7
2014
Q4
$33.1M Sell
1,118,796
-2,635
-0.2% -$75.6K 2% 7
2014
Q3
$31.5M Buy
1,121,431
+28,564
+3% +$802K 1.82% 6
2014
Q2
$30.8M Buy
1,092,867
+1,686
+0.2% +$48.1K 1.95% 6
2014
Q1
$33.3M Sell
1,091,181
-3,689
-0.3% -$110K 1.91% 5
2013
Q4
$31.8M Sell
1,094,870
-2,530
-0.2% -$73.6K 1.82% 5
2013
Q3
$29.9M Buy
1,097,400
+2,825
+0.3% +$76.9K 1.92% 5
2013
Q2
$29.1M Buy
+1,094,575
New +$30.2M 1.91% 5

Other funds holding PFE

TCTC Holdings's PFE Position: Q1 2026 in Review

TCTC Holdings reduced its Pfizer (PFE) stake by 0.17% in Q1 2026, selling an estimated $54.6K and leaving 1,233,510 shares worth $34.6M. The position accounts for 0.99% of the portfolio, ranked #23.

TCTC Holdings first reported a position in PFE in Q2 2013 and has held it in 52 quarters since. The position peaked at $63.6M in Q4 2021. 2,933 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • TCTC Holdings held 1,233,510 shares of Pfizer worth $34.6M as of Q1 2026.
  • TCTC Holdings sold 2,051 Pfizer shares in Q1 2026, an estimated $54.6K.
  • Pfizer made up 0.99% of TCTC Holdings's portfolio in Q1 2026, its #23 holding.
  • TCTC Holdings first reported a position in Pfizer in Q2 2013 and has held it in 52 quarters since.
  • TCTC Holdings's Pfizer position peaked at $63.6M in Q4 2021.
  • 2,933 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on TCTC Holdings's 13F filing for Q1 2026, filed 7 May 2026.